EGFR and adenocarcinoma: Sakuma et al observed the down-regulation of EGFR after generating gefitinib-resistant HCC4006 adenocarcinoma cells – also harbouring the exon 19 E746-A750 deletion – but not in the HCC827 gefitinib-resistant sub-line [13].